120 related articles for article (PubMed ID: 36871636)
21. CoQ
Hseu YC; Thiyagarajan V; Ou TT; Yang HL
Arch Toxicol; 2018 Jan; 92(1):301-322. PubMed ID: 28918503
[TBL] [Abstract][Full Text] [Related]
22. MicroRNA-7 downregulates the oncogene VDAC1 to influence hepatocellular carcinoma proliferation and metastasis.
Wang F; Qiang Y; Zhu L; Jiang Y; Wang Y; Shao X; Yin L; Chen J; Chen Z
Tumour Biol; 2016 Aug; 37(8):10235-46. PubMed ID: 26831666
[TBL] [Abstract][Full Text] [Related]
23. Silencing of Kv1.5 Gene Inhibits Proliferation and Induces Apoptosis of Osteosarcoma Cells.
Wu J; Chen Z; Liu Q; Zeng W; Wu X; Lin B
Int J Mol Sci; 2015 Nov; 16(11):26914-26. PubMed ID: 26569226
[TBL] [Abstract][Full Text] [Related]
24. Simvastatin-Induced Apoptosis in Osteosarcoma Cells: A Key Role of RhoA-AMPK/p38 MAPK Signaling in Antitumor Activity.
Kamel WA; Sugihara E; Nobusue H; Yamaguchi-Iwai S; Onishi N; Maki K; Fukuchi Y; Matsuo K; Muto A; Saya H; Shimizu T
Mol Cancer Ther; 2017 Jan; 16(1):182-192. PubMed ID: 27799356
[TBL] [Abstract][Full Text] [Related]
25. Inhibition of VDAC1 prevents oxidative stress and apoptosis induced by bisphenol A in spermatogonia via AMPK/mTOR signaling pathway.
Wang H; Li Y; Liu C; Lu T; Zhai Q; Wang H; Zhang J
J Toxicol Sci; 2023; 48(3):109-119. PubMed ID: 36858637
[TBL] [Abstract][Full Text] [Related]
26. Antifungal drug itraconazole targets VDAC1 to modulate the AMPK/mTOR signaling axis in endothelial cells.
Head SA; Shi W; Zhao L; Gorshkov K; Pasunooti K; Chen Y; Deng Z; Li RJ; Shim JS; Tan W; Hartung T; Zhang J; Zhao Y; Colombini M; Liu JO
Proc Natl Acad Sci U S A; 2015 Dec; 112(52):E7276-85. PubMed ID: 26655341
[TBL] [Abstract][Full Text] [Related]
27. RNAi-mediated silencing of AQP1 expression inhibited the proliferation, invasion and tumorigenesis of osteosarcoma cells.
Wu Z; Li S; Liu J; Shi Y; Wang J; Chen D; Luo L; Qian Y; Huang X; Wang H
Cancer Biol Ther; 2015; 16(9):1332-40. PubMed ID: 26176849
[TBL] [Abstract][Full Text] [Related]
28. VDAC1 is a molecular target in glioblastoma, with its depletion leading to reprogrammed metabolism and reversed oncogenic properties.
Arif T; Krelin Y; Nakdimon I; Benharroch D; Paul A; Dadon-Klein D; Shoshan-Barmatz V
Neuro Oncol; 2017 Jul; 19(7):951-964. PubMed ID: 28339833
[TBL] [Abstract][Full Text] [Related]
29. Down-regulation of S100A9 inhibits osteosarcoma cell growth through inactivating MAPK and NF-κB signaling pathways.
Cheng S; Zhang X; Huang N; Qiu Q; Jin Y; Jiang D
BMC Cancer; 2016 Mar; 16():253. PubMed ID: 27020242
[TBL] [Abstract][Full Text] [Related]
30. Lidocaine promotes apoptosis in breast cancer cells by affecting VDAC1 expression.
Long D; Fang X; Yuan P; Cheng L; Li H; Qu L
BMC Anesthesiol; 2022 Aug; 22(1):273. PubMed ID: 36042412
[TBL] [Abstract][Full Text] [Related]
31. Effects of MicroRNA-206 on Osteosarcoma Cell Proliferation, Apoptosis, Migration and Invasion by Targeting ANXA2 Through the AKT Signaling Pathway.
Pan BL; Tong ZW; Wu L; Pan L; Li JE; Huang YG; Li SD; Du SX; Li XD
Cell Physiol Biochem; 2018; 45(4):1410-1422. PubMed ID: 29462818
[TBL] [Abstract][Full Text] [Related]
32. LncRNA LINC00628 overexpression inhibits the growth and invasion through regulating PI3K/Akt signaling pathway in osteosarcoma.
He R; Wu JX; Zhang Y; Che H; Yang L
Eur Rev Med Pharmacol Sci; 2018 Sep; 22(18):5857-5866. PubMed ID: 30280767
[TBL] [Abstract][Full Text] [Related]
33. TGF-β is associated with poor prognosis and promotes osteosarcoma progression
Ma K; Zhang C; Li W
Cell Cycle; 2020 Sep; 19(18):2327-2339. PubMed ID: 32804027
[TBL] [Abstract][Full Text] [Related]
34. Silencing microRNA-27a inhibits proliferation and invasion of human osteosarcoma cells through the SFRP1-dependent Wnt/β-catenin signaling pathway.
Mu Y; Zhang L; Chen X; Chen S; Shi Y; Li J
Biosci Rep; 2019 Jun; 39(6):. PubMed ID: 31072914
[TBL] [Abstract][Full Text] [Related]
35. p38 MAPK regulates the expression of ether à go-go potassium channel in human osteosarcoma cells.
Wu X; Zhong D; Lin B; Zhai W; Ding Z; Wu J
Radiol Oncol; 2013 Mar; 47(1):42-9. PubMed ID: 23450231
[TBL] [Abstract][Full Text] [Related]
36. HIF-2α affects proliferation and apoptosis of MG-63 osteosarcoma cells through MAPK signaling.
Wang Y; Wang X; Su X; Liu T
Mol Med Rep; 2017 Apr; 15(4):2174-2178. PubMed ID: 28259908
[TBL] [Abstract][Full Text] [Related]
37. Highly-expressed P2X7 receptor promotes growth and metastasis of human HOS/MNNG osteosarcoma cells via PI3K/Akt/GSK3β/β-catenin and mTOR/HIF1α/VEGF signaling.
Zhang Y; Cheng H; Li W; Wu H; Yang Y
Int J Cancer; 2019 Aug; 145(4):1068-1082. PubMed ID: 30761524
[TBL] [Abstract][Full Text] [Related]
38. AIM2 inhibits the proliferation, invasion and migration, and promotes the apoptosis of osteosarcoma cells by inactivating the PI3K/AKT/mTOR signaling pathway.
Zheng J; Liu C; Shi J; Wen K; Wang X
Mol Med Rep; 2022 Feb; 25(2):. PubMed ID: 34913077
[TBL] [Abstract][Full Text] [Related]
39. Downregulation of long non-coding RNA DBH-AS1 inhibits osteosarcoma progression by PI3K-AKT signaling pathways and indicates good prognosis.
Liu ZB; Wang JA; Lv RQ
Eur Rev Med Pharmacol Sci; 2019 Feb; 23(4):1418-1427. PubMed ID: 30840262
[TBL] [Abstract][Full Text] [Related]
40. Calponin 3 is associated with poor prognosis and regulates proliferation and metastasis in osteosarcoma.
Dai F; Luo F; Zhou R; Zhou Q; Xu J; Zhang Z; Xiao J; Song L
Aging (Albany NY); 2020 Jul; 12(14):14037-14049. PubMed ID: 32667904
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
